Xponance’s Cantel Medical Corporation CMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-4,125
Closed -$329K 1270
2021
Q1
$329K Sell
4,125
-907
-18% -$70.8K 0.01% 936
2020
Q4
$397K Buy
5,032
+4
+0.1% +$235 0.01% 847
2020
Q3
$221K Sell
5,028
-49
-1% -$2.41K 0.01% 949
2020
Q2
$225K Buy
+5,077
New +$189K 0.01% 928

Xponance's CMD Position: Q2 2021 in Review

Xponance sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 4,125 shares — an estimated $329K sold.

Xponance first reported a position in CMD in Q2 2020 and held it in 4 quarters. The position peaked at $397K in Q4 2020. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.

  • Xponance reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
  • Xponance sold 4,125 Cantel Medical Corporation shares in Q2 2021, an estimated $329K.
  • Xponance first reported a position in Cantel Medical Corporation in Q2 2020 and held it in 4 quarters.
  • Xponance's Cantel Medical Corporation position peaked at $397K in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.

Based on Xponance's 13F filing for Q2 2021, filed 12 Aug 2021.